Christoph Liebetrau
Overview
Explore the profile of Christoph Liebetrau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
243
Citations
3576
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dorr O, Keranov S, van Wickern P, Nef H, Hamm C, Bauer P, et al.
ESC Heart Fail
. 2024 Dec;
PMID: 39654310
Aims: SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N-terminal pro-brain natriuretic protein (NT-proBNP) is an established biomarker of...
2.
Sanchez-Sanchez I, Cerrato E, Bollati M, Espejo-Paeres C, Nombela-Franco L, Alfonso-Rodriguez E, et al.
JACC Cardiovasc Interv
. 2024 Nov;
17(22):2681-2691.
PMID: 39603781
Background: Limited data are available to guide the management of coronary artery aneurysms (CAAs). Objectives: The authors sought to define the clinical characteristics, identify variables that predict outcomes, and provide...
3.
Piayda K, Keranov S, Schulz L, Arsalan M, Liebetrau C, Kim W, et al.
Clin Res Cardiol
. 2024 Oct;
PMID: 39453458
Background: Risk prediction in patients with severe, symptomatic aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) remains an unsolved issue. In addition to classical risk scoring systems, novel circulating...
4.
Jurida L, Werner S, Knapp F, Niemann B, Li L, Grun D, et al.
Nat Cardiovasc Res
. 2024 Aug;
3(7):819-840.
PMID: 39196177
The molecular mechanisms of progressive right heart failure are incompletely understood. In this study, we systematically examined transcriptomic changes occurring over months in isolated cardiomyocytes or whole heart tissues from...
5.
Weferling M, Rolf A, Treiber J, Fischer-Rasokat U, Liebetrau C, Hamm C, et al.
BMC Cardiovasc Disord
. 2024 May;
24(1):253.
PMID: 38750455
Background: Primary coronary slow flow (CSF) is defined as delayed opacification of the distal epicardial vasculature during coronary angiography in the absence of relevant coronary artery stenoses. Microvascular disease is...
6.
Aytekin A, Scalamogna M, Coughlan J, Lahu S, Ndrepepa G, Menichelli M, et al.
Clin Res Cardiol
. 2024 May;
113(7):1060-1069.
PMID: 38740722
Background: The ISAR-REACT 5 trial compared the efficacy and safety of ticagrelor and prasugrel in patients with ACS managed invasively. The present study sought to investigate the impact of ticagrelor...
7.
Piayda K, Heilemann J, Keranov S, Schulz L, Arsalan M, Liebetrau C, et al.
Biomarkers
. 2024 Apr;
29(4):205-210.
PMID: 38588595
Background: Currently available risk scores fail to accurately predict morbidity and mortality in patients with severe symptomatic aortic stenosis who undergo transcatheter aortic valve implantation (TAVI). In this context, biomarkers...
8.
Borlich M, Zeymer U, Wienbergen H, Hobbach H, Cuneo A, Bekeredjian R, et al.
Cardiol Ther
. 2023 Dec;
13(1):89-101.
PMID: 38055177
Introduction: The preference for using transradial access (TRA) over transfemoral access (TFA) in patients requiring percutaneous coronary intervention (PCI) is based on evidence suggesting that TRA is associated with less...
9.
Wiedenroth C, Steinhaus K, Rolf A, Breithecker A, Adameit M, Kriechbaum S, et al.
Thorac Cardiovasc Surg
. 2023 Aug;
PMID: 37643729
Background: Balloon pulmonary angioplasty (BPA) is a promising interventional treatment for inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Evidence in favor of BPA is growing, but long-term data remain scarce. The...
10.
Desch S, Freund A, Akin I, Behnes M, Preusch M, Zelniker T, et al.
JAMA Cardiol
. 2023 Aug;
8(9):827-834.
PMID: 37556123
Importance: Myocardial infarction is a frequent cause of out-of-hospital cardiac arrest (OHCA). The long-term effect of early coronary angiography on patients with OHCA with possible coronary trigger but no ST-segment...